COLGALT1

Across TCGA pan-cancer cohorts, COLGALT1 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated COLGALT1 data layer compared with 23 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher COLGALT1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated COLGALT1 expression acts as an unfavorable survival marker.

CCRCC, HNSC, and LUAD are the cancer types where COLGALT1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Quartile	III,IV	0.320	0.923	<.001	63	view →
HNSC	DFS	Median	IV	0.547	0.810	.006	31	view →
LUAD	DFS	Quartile	All	0.643	1.000	.018	9	view →
PDAC	DFS	Median	All	0.320	0.497	.004	9	view →
UCEC	DFS	Quartile	All	0.754	0.961	.015	8	view →
GBM	DFS	Quartile	All	0.272	0.512	.015	6	view →
LSCC	OS	Median	II,III,IV	0.772	0.891	.026	2	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

COLGALT1–CCRCC (OS)

Open the CCRCC breakdown →